PerkinElmer
check quantity

IVISense Tumor Metabolism Fluorescent Imaging Panel

Advance your understanding of cancer using IVISense Tumor Metabolism Fluorescent Imaging Panel specific for measuring and detecting tumor metabolism in vivo.

For research use only. Not for use in diagnostic procedures.

Part Number
List Price
Your Price
Quantity
NEV20015
3961.00 USD
 
more
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

Tumors modify the cellular metabolism in cancer cells when compared to normal healthy cells. They alter pathways of nutrient acquisition and metabolism to meet increased energy, synthetic, and proliferative demands. Biomarkers of tumor metabolism offer not only opportunities to study tumor progression but also to specifically assess therapies that target critical pathways in tumor metabolism. Our fluorescent imaging probes provide a variety of tools for quantifying key receptors associated with proliferation and nutrient uptake as well as biomarkers of cell death, protease activity, and vascular leak.

The availability of probes at 680 nm and 750 nm wavelengths further offer the opportunity for multiplex imaging of appropriate probe combinations to maximize information gained from research animals.

 

Our IVISense Tumor Metaolism Fluorescent Imaging Panel includes the following seven probes:

Part Number Fluorescent Probe Biological Target
NEV10054EX IVISense Vascular 680 (AngioSense 680EX) Vascular probe:
Leaks into sites of edema
NEV10168  IVISense MMP 750 FAST  (MMPSense 750 FAST) Pan-MMP activatable probe:
Secreted marker of neutrophils, macrophages, and mast cells
NEV10003  IVISense Pan Cathepsin 680 (ProSense 680) Pan-cathepsin activatable probe:
Lysosomal marker of a variety of inflammatory cells
NEV10040 IVISense Folate Receptor 680 (FolateRSense 680) Folate receptor targeted probe:
Marker on inflammatory cells; metabolic marker on tumor cells
NEV10090 IVISense Bombesin Receptor 680 (BombesinRSense 680) Bombesin receptor targeted probe:
Metabolic marker on tumor cells
NEV10091 IVISense Transferrin Receptor 750  (Transferrin-Vivo 750) Transferrin receptor targeted probe:
Iron metabolism marker on tumor cells
NEV11053  IVISense Annexin-V 750 Fluorescent Probe (Annexin-Vivo) Death/apoptosis probe:
Detects surface phosphatidylserine increase on dying cells

Specifications

Optical Imaging Classification Fluorescence Imaging
Product Brand Name IVISense
Quantity in a Package Amount 7.0 Vials
Shipping Condition Blue Ice
Therapeutic Area Tumor Metabolism
Resources, Events & More
  • All

Ebook

In Vivo Imaging Solutions eBook

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And our hard-earned expertise makes us a trusted provider of pre-clinical imaging solutions— with more than 9,000 peer reviewed articles as proof.

PDF 4 MB

Flyer

Best Practices for Designing An Effective In Vivo Fluorescence Imaging Study

Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into disease processes and treatment effects. Designing an effective study from the beginning can help save time and resources.

Learn about several important best practices, from proper probe selection to study design to imaging technique tips and tricks needed to generate meaningful biological information from your in vivo fluorescence imaging studies.

PDF 507 KB
Fluorescent Panels Targeted for Your Research

Data sheet on PerkinElmer's Fluorescent Panels for In Vivo imaging

PDF 706 KB

Guide

Fluorescent Imaging Panels (User Guide)

User guide for fluorescent imaging probes

PDF 800 KB

White Paper

The Role of In Vivo Imaging in Drug Discovery and Development

The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick and efficient drug screening and evaluation. Read this White Paper to learn how preclinical in vivo imaging helps to ensure that smart choices are made by providing Go/No-Go decisions and de-risking drug candidates early on, significantly reducing time to the clinic and lowering costs all while maximizing biological understanding.

PDF 547 KB